PROSTATIC NEOPLASM
Clinical trials for PROSTATIC NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASM trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested a combination of two drugs, abiraterone acetate and prednisone, in 131 men with advanced prostate cancer that had not yet spread to other parts of the body. The goal was to see if the treatment could lower PSA levels (a marker of cancer activity) and delay the t…
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
New combo therapy aims to cut hormone therapy for prostate cancer patients
Disease control CompletedThis early-phase study tested a new treatment approach for men with prostate cancer that has spread to nearby lymph nodes. The standard treatment uses radiation plus 2-3 years of hormone therapy, which can cause lasting side effects. Researchers added a targeted radioactive drug …
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control CompletedThis study tested a radioactive drug (I-131-1095) that targets prostate cancer cells. It included 120 men whose cancer had stopped responding to the drug abiraterone. Some men received the radioactive drug plus enzalutamide, while others got enzalutamide alone. The main goal was …
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Second-Chance radiation: new hope for men with recurrent prostate cancer?
Disease control CompletedThis early-stage study tested a very focused type of radiation (SBRT) given in just 5 sessions to men whose prostate cancer returned after earlier radiation. The goal was to find the highest safe dose and see what side effects occur. Seventeen men took part, and the study is now …
Matched conditions: PROSTATIC NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
New EHR tool aims to boost heart health talks for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool that helps doctors and cancer survivors discuss heart health during follow-up visits. About 645 survivors of breast, prostate, colorectal, endometrial, and lymphoma cancers took part. The goal was to see if the tool leads to more conversations ab…
Matched conditions: PROSTATIC NEOPLASM
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 03:03 UTC